Overview of Abraxane.com
Abraxane.com was first analyzed by us on Jun 17, 2013.
We can see that the website is ONLINE.
It currently ranks #2,849,999 in the world according to Alexa.
The lower the Alexa Rank, the better and this is in our opinion a good starting rank.
It is most popular in United States where it currently ranks #495,943.
The website has a good Google PageRank of 5.
The IP address of the server abraxane.com is hosted on is 207.99.80.213
and is based in Newark, United States
.
Name: |
Abraxane |
Website URL: |
www.abraxane.com |
Page Rank: |
 |
Alexa Rank: |
#2,849,999
|
Country Rank: |
#495,943 |
Most Popular In: |
United States |
Website Speed: |
0.292 seconds |
Language: |
English |
Back Links (Alexa) |
74 |
Popular Keywords: |
Abraxane, Patients, Severe, Reactions, Paclitaxel, Neutropenia, Nsclc
|
Websites Like Abraxane.com
Social Statistics
Facebook Stats |
Likes: |
10 |
Shares: |
15 |
Clicks: |
0 |
Comments: |
23 |
Website's On-page Analysis
HTML Tag Elements |
Paragraph: |
12 |
Strong: |
10 |
Tables: |
0 |
Lists: |
43 |
Total Images: |
7 |
Missing Alt: |
0 |
Internal Links: |
23 |
External Links: |
8 |
Forms: |
1 |
Fields: |
8 |
Page Headings |
H1 Tags: |
2 |
H2 Tags: |
16 |
H3 Tags: |
30 |
H4 Tags: |
0 |
H5 Tags: |
0 |
H6 Tags: |
0 |
Includes |
Iframe: |
0 |
Flash: |
0 |
CSS: |
5 |
Scripts: |
10 |
Page Statistics |
File Size: |
57.44 KB |
Word Count: |
1745 |
Charset: |
UTF-8 |
Doctype: |
Yes |
Viewport: |
Yes |
Google Analytics: |
Yes |
Webmaster Tools: |
Yes |
Bing Webmaster Tools: |
No |
Meta elements are HTML elements used to provide structured metadata about a Web page.
We have listed below the meta elements we have extracted from abraxane.com.
Name |
Contents |
Title Tag: |
ABRAXANE.com | Official Site | ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) |
Description Tag: |
ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound); indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemothe... |
Keywords Tag: |
ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound), Treatment for Advanced Breast Cancer, Chemotheraphy Treatment for metastatic breast cancer, late stage mBC, Efficacy, Important Safety Information, clinical trial research, adverse events, safety profile, dosing administration, dosing modifications |
X-UA-Compatible |
IE=edge,chrome=1 |
viewport |
width=device-width |
author |
Celgene ABRAXANE |
Copyright |
Copyright Celgene ABRAXANE 2013. All Rights Reserved. |
DC.creator |
Weber Shandwick |
DC.title |
ABRAXANE.com | Official Site | ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) |
google-site-verification |
BnQD5a1v__2-_6w_XF_OpTqweWnPYhENTuYllciA4gY |
title |
Official Site for ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) |
Web Server Location
IP Address: |
207.99.80.213 |
Location: |
07101, Newark, New Jersey, United States |
Timezone: |
-04:00 |
|
Traffic Report
Alexa Global Rank: |
|
Compete: |
|
Quantcast: |
|
Website WOT Rating
WOT is a website reputation system that identifies trustworthy websites and protects against online scams, untrustworthy links, and unreliable web stores.
Reputation ratings are based on real user ratings and they tell you how much other users trust this site.
Description |
Score |
Confidence |
Trustworthiness: |
61/100 - Good |
4/100 - |
Keyword Analysis
We have attempted to list all keywords that have been repeated more than once and are topic related.
# |
Keyword |
Repeated |
Density |
1 | abraxane | 296 | 16.96% |
2 | patients | 169 | 9.68% |
3 | severe | 156 | 8.94% |
4 | reactions | 108 | 6.19% |
5 | paclitaxel | 80 | 4.58% |
6 | neutropenia | 78 | 4.47% |
7 | nsclc | 67 | 3.84% |
8 | neuropathy | 66 | 3.78% |
9 | cells | 60 | 3.44% |
10 | drug | 54 | 3.09% |
11 | mbc | 51 | 2.92% |
12 | peripheral | 48 | 2.75% |
13 | combination | 42 | 2.41% |
14 | impairment | 2 | 0.11% |
15 | common | 2 | 0.11% |
16 | injection | 2 | 0.11% |
17 | hypersensitivity | 2 | 0.11% |
18 | dose | 2 | 0.11% |
19 | carboplatin | 2 | 0.11% |
20 | adverse | 2 | 0.11% |
Website's HTTP Request
Name |
Content |
Cache-Control | public |
---|
Content-Type | text/html; charset=utf-8 |
---|
Expires | Thu, 08 Aug 2013 03 |
---|
Server | Microsoft-IIS/7.5 |
---|
X-AspNet-Version | 2.0.50727 |
---|
X-Powered-By | ASP.NET |
---|
Date | Thu, 08 Aug 2013 02 |
---|
Content-Length | 58810 |
Add a widget to your website to gain more user confidence. Just copy & paste the html snippet into your website!